Skip to content
10-Q

Quarterly Report

GlobeStar Therapeutics Corp

0001161697-23-000103

← back to feed
Filed
Feb 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Feb 9, 2023 770.36M sh
Cash And Equivalents Q1 2023 · Dec 31, 2022 $7.72K
Cash And Equivalents Q1 2023 · Sep 30, 2022 $6.37K
Cash And Equivalents Q1 2023 · Dec 31, 2021 $21.43K
Cash And Equivalents Q1 2023 · Sep 30, 2021 $5.96K
Current Liabilities Q1 2023 · Dec 31, 2022 $1.25M
Current Liabilities Q1 2023 · Sep 30, 2022 $1.2M
Total Liabilities Q1 2023 · Dec 31, 2022 $1.25M
Total Liabilities Q1 2023 · Sep 30, 2022 $1.2M
Current Assets Q1 2023 · Dec 31, 2022 $10.22K
Current Assets Q1 2023 · Sep 30, 2022 $9.92K
Total Assets Q1 2023 · Dec 31, 2022 $10.22K
Total Assets Q1 2023 · Sep 30, 2022 $9.92K
Stock Issued Q1 2023 · Feb 28, 2022 6M sh
Operating Cash Flow Q1 2023 · Dec 31, 2021 −$129.54K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$897.2K
Stockholders Equity Q1 2023 · Sep 30, 2021 −$725.82K
Net Income Q1 2023 · Dec 31, 2021 −$332.84K
Operating Income Q1 2023 · Dec 31, 2021 −$166.29K